In contrast, genes dependent for only a subset of cell lines (e.g., TTK) might represent better therapeutic targets, as these could involve uniquely targetable dependencies for a subset of cancers, e.g., genes involved in “oncogene addiction” [40–42]. Here, TTK is linked to cancer.